Atlas Trials

Biocon Biologics UK Ltd

5 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Biocon Biologics UK Ltd

RecordFirmDate
This is Comparative Study in Normal Healthy Subjects to Evaluate Pharmacokinetics, Safety, Tolerability of Bmab 1200 -Autoinjector (AI) After Single Subcutaneous Injection (45 mg) in Comparison With Bmab 1200 -Prefilled Syringe (PFS). (NCT06738277)Biocon Biologics UK Ltd2025-01-09
Efficacy and Safety of the Proposed Biosimilar Pertuzumab (PERT-IJS) Versus EU-Perjeta® Along With Trastuzumab and Chemotherapy (Carboplatin and Docetaxel) as Neoadjuvant Treatment in Chemotherapy naïve Patients With Early Stage or Locally Advanced HR Negative and HER2 Positive Breast Cancer (NCT06038539)Biocon Biologics UK Ltd2025-01-06
Comparing Efficacy and Safety of Bmab 1200 and Stelara in Patients With Moderate to Severe Chronic Plaque Psoriasis (NCT05335356)Biocon Biologics UK Ltd2022-06-28
Comparison of Efficacy, Pharmacodynamics, Safety, and Immunogenicity Between Bmab 1000 and Prolia® in Postmenopausal Women With Osteoporosis (NCT05345691)Biocon Biologics UK Ltd2022-05-24
Comparison of Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Bmab 1000 and Prolia® in Normal Healthy Volunteers: DENARIUS: DENosumab Pharmacokinetic equivAlence tRIal in Healthy volUnteerS (NCT05323708)Biocon Biologics UK Ltd2022-03-09

Track Biocon Biologics UK Ltd automatically

Every clearance here is in the API, with alerts when new ones post.